HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-JUN-11 3SA0 TITLE COMPLEX OF ERK2 WITH NORATHYRIOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE 1, MAPK 1, ERT1, EXTRACELLULAR SIGNAL-REGULATED COMPND 5 KINASE 2, ERK-2, MAP KINASE ISOFORM P42, P42-MAPK, MITOGEN-ACTIVATED COMPND 6 PROTEIN KINASE 2, MAP KINASE 2, MAPK 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ERK2, MAPK1, PRKM1, PRKM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS (DE3)-RIPL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-28A KEYWDS NORATHYRIOL COMPLEX, SIGNAL-REGULATED KINASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.KURINOV,M.MALAKHOVA REVDAT 4 30-OCT-24 3SA0 1 REMARK REVDAT 3 13-SEP-23 3SA0 1 REMARK LINK REVDAT 2 18-JAN-12 3SA0 1 JRNL REVDAT 1 14-DEC-11 3SA0 0 JRNL AUTH J.LI,M.MALAKHOVA,M.MOTTAMAL,K.REDDY,I.KURINOV,A.CARPER, JRNL AUTH 2 A.LANGFALD,N.OI,M.O.KIM,F.ZHU,C.P.SOSA,K.ZHOU,A.M.BODE, JRNL AUTH 3 Z.DONG JRNL TITL NORATHYRIOL SUPPRESSES SKIN CANCERS INDUCED BY SOLAR JRNL TITL 2 ULTRAVIOLET RADIATION BY TARGETING ERK KINASES. JRNL REF CANCER RES. V. 72 260 2012 JRNL REFN ISSN 0008-5472 JRNL PMID 22084399 JRNL DOI 10.1158/0008-5472.CAN-11-2596 REMARK 2 REMARK 2 RESOLUTION. 1.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.1_743) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.59 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.57 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 49907 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1997 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.5730 - 3.8409 0.99 3476 145 0.1713 0.2133 REMARK 3 2 3.8409 - 3.0496 1.00 3456 139 0.1631 0.1913 REMARK 3 3 3.0496 - 2.6644 1.00 3473 141 0.1653 0.1871 REMARK 3 4 2.6644 - 2.4209 1.00 3418 152 0.1534 0.1986 REMARK 3 5 2.4209 - 2.2475 1.00 3453 144 0.1522 0.1818 REMARK 3 6 2.2475 - 2.1150 1.00 3425 131 0.1494 0.1853 REMARK 3 7 2.1150 - 2.0091 1.00 3432 154 0.1525 0.1847 REMARK 3 8 2.0091 - 1.9217 1.00 3397 149 0.1486 0.1986 REMARK 3 9 1.9217 - 1.8477 1.00 3445 135 0.1533 0.1783 REMARK 3 10 1.8477 - 1.7840 1.00 3442 146 0.1611 0.1985 REMARK 3 11 1.7840 - 1.7282 1.00 3371 147 0.1778 0.2077 REMARK 3 12 1.7282 - 1.6788 1.00 3425 141 0.1969 0.2455 REMARK 3 13 1.6788 - 1.6346 1.00 3443 132 0.2119 0.2807 REMARK 3 14 1.6346 - 1.5947 0.95 3254 141 0.2220 0.2811 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.65 REMARK 3 K_SOL : 0.44 REMARK 3 B_SOL : 52.79 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.130 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.65630 REMARK 3 B22 (A**2) : 2.26090 REMARK 3 B33 (A**2) : 1.39530 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.21720 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.014 3029 REMARK 3 ANGLE : 1.459 4114 REMARK 3 CHIRALITY : 0.083 446 REMARK 3 PLANARITY : 0.008 527 REMARK 3 DIHEDRAL : 14.311 1149 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESID 4:109) REMARK 3 ORIGIN FOR THE GROUP (A): -13.8016 12.4748 31.7206 REMARK 3 T TENSOR REMARK 3 T11: 0.3078 T22: 0.3682 REMARK 3 T33: 0.2032 T12: 0.0630 REMARK 3 T13: -0.0004 T23: 0.0753 REMARK 3 L TENSOR REMARK 3 L11: 1.5722 L22: 0.4521 REMARK 3 L33: 2.6284 L12: -0.4804 REMARK 3 L13: -0.3316 L23: -0.3531 REMARK 3 S TENSOR REMARK 3 S11: 0.0392 S12: 0.1127 S13: 0.5350 REMARK 3 S21: 0.0976 S22: 0.1579 S23: 0.0366 REMARK 3 S31: -0.6393 S32: -0.5935 S33: -0.0454 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN A AND RESID 110:336 ) REMARK 3 ORIGIN FOR THE GROUP (A): 0.0135 6.7031 55.8008 REMARK 3 T TENSOR REMARK 3 T11: 0.1103 T22: 0.0798 REMARK 3 T33: 0.1302 T12: 0.0294 REMARK 3 T13: 0.0138 T23: 0.0062 REMARK 3 L TENSOR REMARK 3 L11: 2.1144 L22: 0.7960 REMARK 3 L33: 1.0396 L12: 0.8266 REMARK 3 L13: 0.3024 L23: 0.0862 REMARK 3 S TENSOR REMARK 3 S11: 0.0356 S12: 0.0307 S13: 0.1649 REMARK 3 S21: -0.0109 S22: -0.0073 S23: -0.0158 REMARK 3 S31: -0.0170 S32: 0.0388 S33: -0.0288 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: (CHAIN A AND RESID 337:360) REMARK 3 ORIGIN FOR THE GROUP (A): -5.3942 5.4077 21.9543 REMARK 3 T TENSOR REMARK 3 T11: 0.3299 T22: 0.3453 REMARK 3 T33: 0.1930 T12: 0.0356 REMARK 3 T13: -0.0094 T23: -0.0062 REMARK 3 L TENSOR REMARK 3 L11: 1.9812 L22: 1.2564 REMARK 3 L33: 4.6229 L12: -0.7482 REMARK 3 L13: 2.2463 L23: -0.9472 REMARK 3 S TENSOR REMARK 3 S11: 0.3193 S12: 0.5351 S13: -0.4496 REMARK 3 S21: -0.1841 S22: 0.0594 S23: -0.3511 REMARK 3 S31: 0.2512 S32: 0.4101 S33: -0.3398 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3SA0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1000065948. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-DEC-09; NULL REMARK 200 TEMPERATURE (KELVIN) : 100; NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 3 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : APS; APS REMARK 200 BEAMLINE : 24-ID-E; 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795; 0.9795 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTALS MONOCHROMATOR; REMARK 200 NULL REMARK 200 OPTICS : HF AND VF MIRRORS; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; NULL REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49914 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.595 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 15.30 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.59 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.50 REMARK 200 R MERGE FOR SHELL (I) : 0.80200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 1TVO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PRECIPITANT: 1.1 M - 1.3 M AMMONIUM REMARK 280 SULFATE, 2% PEG 500 MME, 0.1 M HEPES, PH 7.5. THE PROTEIN WAS IN REMARK 280 80-120 MM NACL, TRIS 15 MM, PH 8.0, 10-20 MM B-ME PROTEIN WAS REMARK 280 MIXED WITH PRECIPITANT AT 1:1 RATIO, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.70550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 330 CG CD CE NZ REMARK 470 ASP A 337 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HG11 VAL A 273 HH12 ARG A 277 1.29 REMARK 500 HZ3 LYS A 300 O HOH A 630 1.35 REMARK 500 HE21 GLN A 355 O HOH A 435 1.46 REMARK 500 HH21 ARG A 353 O HOH A 611 1.53 REMARK 500 HZ3 LYS A 114 O HOH A 614 1.54 REMARK 500 O HOH A 606 O HOH A 642 1.81 REMARK 500 ND2 ASN A 238 O HOH A 584 1.84 REMARK 500 OH TYR A 36 OG1 THR A 68 1.99 REMARK 500 O HOH A 569 O HOH A 599 2.03 REMARK 500 O HOH A 555 O HOH A 581 2.04 REMARK 500 O HOH A 614 O HOH A 616 2.05 REMARK 500 O HOH A 444 O HOH A 516 2.07 REMARK 500 OXT SER A 360 O HOH A 508 2.07 REMARK 500 NZ LYS A 114 O HOH A 614 2.10 REMARK 500 NE2 HIS A 180 O HOH A 539 2.11 REMARK 500 OD1 ASP A 20 O HOH A 618 2.11 REMARK 500 CG ASN A 238 O HOH A 584 2.14 REMARK 500 OE1 GLU A 326 O HOH A 420 2.14 REMARK 500 O HOH A 523 O HOH A 545 2.15 REMARK 500 OD2 ASP A 283 O HOH A 561 2.15 REMARK 500 O HOH A 461 O HOH A 538 2.16 REMARK 500 NZ LYS A 300 O HOH A 630 2.19 REMARK 500 OD1 ASN A 257 O HOH A 539 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 HZ2 LYS A 270 O HOH A 437 2657 1.57 REMARK 500 O ARG A 359 O HOH A 630 1454 2.02 REMARK 500 O HOH A 512 O HOH A 549 2647 2.08 REMARK 500 NZ LYS A 270 O HOH A 437 2657 2.10 REMARK 500 OD1 ASN A 238 O HOH A 550 2657 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 5 -4.01 104.05 REMARK 500 ALA A 6 -9.77 -53.45 REMARK 500 PRO A 11 -109.44 -52.73 REMARK 500 GLU A 12 -126.97 74.04 REMARK 500 VAL A 14 -66.54 69.21 REMARK 500 ARG A 15 33.31 137.99 REMARK 500 GLN A 17 -91.65 -62.09 REMARK 500 LEU A 28 64.17 -104.78 REMARK 500 ILE A 31 -57.06 -123.64 REMARK 500 TYR A 36 63.63 -169.47 REMARK 500 THR A 110 -175.41 -172.14 REMARK 500 ARG A 148 -0.79 75.15 REMARK 500 ASP A 149 42.09 -143.67 REMARK 500 ASP A 167 82.33 68.16 REMARK 500 ASP A 175 71.41 -155.79 REMARK 500 ASN A 201 19.96 -161.82 REMARK 500 LEU A 294 50.02 -95.86 REMARK 500 ASP A 318 92.04 -160.18 REMARK 500 ASP A 337 31.02 -96.87 REMARK 500 TYR A 358 57.25 -148.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NRA A 361 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 362 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TVO RELATED DB: PDB DBREF 3SA0 A 1 360 UNP P28482 MK01_HUMAN 1 360 SEQRES 1 A 360 MET ALA ALA ALA ALA ALA ALA GLY ALA GLY PRO GLU MET SEQRES 2 A 360 VAL ARG GLY GLN VAL PHE ASP VAL GLY PRO ARG TYR THR SEQRES 3 A 360 ASN LEU SER TYR ILE GLY GLU GLY ALA TYR GLY MET VAL SEQRES 4 A 360 CYS SER ALA TYR ASP ASN VAL ASN LYS VAL ARG VAL ALA SEQRES 5 A 360 ILE LYS LYS ILE SER PRO PHE GLU HIS GLN THR TYR CYS SEQRES 6 A 360 GLN ARG THR LEU ARG GLU ILE LYS ILE LEU LEU ARG PHE SEQRES 7 A 360 ARG HIS GLU ASN ILE ILE GLY ILE ASN ASP ILE ILE ARG SEQRES 8 A 360 ALA PRO THR ILE GLU GLN MET LYS ASP VAL TYR ILE VAL SEQRES 9 A 360 GLN ASP LEU MET GLU THR ASP LEU TYR LYS LEU LEU LYS SEQRES 10 A 360 THR GLN HIS LEU SER ASN ASP HIS ILE CYS TYR PHE LEU SEQRES 11 A 360 TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER ALA SEQRES 12 A 360 ASN VAL LEU HIS ARG ASP LEU LYS PRO SER ASN LEU LEU SEQRES 13 A 360 LEU ASN THR THR CME ASP LEU LYS ILE CME ASP PHE GLY SEQRES 14 A 360 LEU ALA ARG VAL ALA ASP PRO ASP HIS ASP HIS THR GLY SEQRES 15 A 360 PHE LEU THR GLU TYR VAL ALA THR ARG TRP TYR ARG ALA SEQRES 16 A 360 PRO GLU ILE MET LEU ASN SER LYS GLY TYR THR LYS SER SEQRES 17 A 360 ILE ASP ILE TRP SER VAL GLY CYS ILE LEU ALA GLU MET SEQRES 18 A 360 LEU SER ASN ARG PRO ILE PHE PRO GLY LYS HIS TYR LEU SEQRES 19 A 360 ASP GLN LEU ASN HIS ILE LEU GLY ILE LEU GLY SER PRO SEQRES 20 A 360 SER GLN GLU ASP LEU ASN CME ILE ILE ASN LEU LYS ALA SEQRES 21 A 360 ARG ASN TYR LEU LEU SER LEU PRO HIS LYS ASN LYS VAL SEQRES 22 A 360 PRO TRP ASN ARG LEU PHE PRO ASN ALA ASP SER LYS ALA SEQRES 23 A 360 LEU ASP LEU LEU ASP LYS MET LEU THR PHE ASN PRO HIS SEQRES 24 A 360 LYS ARG ILE GLU VAL GLU GLN ALA LEU ALA HIS PRO TYR SEQRES 25 A 360 LEU GLU GLN TYR TYR ASP PRO SER ASP GLU PRO ILE ALA SEQRES 26 A 360 GLU ALA PRO PHE LYS PHE ASP MET GLU LEU ASP ASP LEU SEQRES 27 A 360 PRO LYS GLU LYS LEU LYS GLU LEU ILE PHE GLU GLU THR SEQRES 28 A 360 ALA ARG PHE GLN PRO GLY TYR ARG SER MODRES 3SA0 CME A 161 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3SA0 CME A 166 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3SA0 CME A 254 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 161 18 HET CME A 166 18 HET CME A 254 19 HET NRA A 361 19 HET SO4 A 362 5 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM NRA NORATHYRIOL HETNAM SO4 SULFATE ION HETSYN NRA 1,3,6,7-TETRAHYDROXY-9H-XANTHEN-9-ONE FORMUL 1 CME 3(C5 H11 N O3 S2) FORMUL 2 NRA C13 H8 O6 FORMUL 3 SO4 O4 S 2- FORMUL 4 HOH *296(H2 O) HELIX 1 1 HIS A 61 PHE A 78 1 18 HELIX 2 2 LEU A 112 GLN A 119 1 8 HELIX 3 3 SER A 122 ALA A 143 1 22 HELIX 4 4 LYS A 151 SER A 153 5 3 HELIX 5 5 ASP A 175 ASP A 179 5 5 HELIX 6 6 THR A 190 ARG A 194 5 5 HELIX 7 7 ALA A 195 ASN A 201 1 7 HELIX 8 8 LYS A 207 ASN A 224 1 18 HELIX 9 9 HIS A 232 GLY A 245 1 14 HELIX 10 10 SER A 248 CME A 254 1 7 HELIX 11 11 ASN A 257 LEU A 267 1 11 HELIX 12 12 PRO A 274 PHE A 279 1 6 HELIX 13 13 ASP A 283 LEU A 294 1 12 HELIX 14 14 GLU A 303 ALA A 309 1 7 HELIX 15 15 HIS A 310 GLU A 314 5 5 HELIX 16 16 ASP A 318 GLU A 322 5 5 HELIX 17 17 PRO A 339 THR A 351 1 13 HELIX 18 18 ALA A 352 GLN A 355 5 4 SHEET 1 A 5 SER A 29 GLU A 33 0 SHEET 2 A 5 MET A 38 ASP A 44 -1 O SER A 41 N SER A 29 SHEET 3 A 5 VAL A 49 ILE A 56 -1 O VAL A 49 N ASP A 44 SHEET 4 A 5 VAL A 101 ASP A 106 -1 O VAL A 101 N ILE A 56 SHEET 5 A 5 ASP A 88 ILE A 90 -1 N ASP A 88 O VAL A 104 SHEET 1 B 3 THR A 110 ASP A 111 0 SHEET 2 B 3 LEU A 155 LEU A 157 -1 O LEU A 157 N THR A 110 SHEET 3 B 3 LEU A 163 ILE A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 C 2 VAL A 145 LEU A 146 0 SHEET 2 C 2 ARG A 172 VAL A 173 -1 O ARG A 172 N LEU A 146 LINK C THR A 160 N CME A 161 1555 1555 1.33 LINK C CME A 161 N ASP A 162 1555 1555 1.33 LINK C ILE A 165 N CME A 166 1555 1555 1.31 LINK C CME A 166 N ASP A 167 1555 1555 1.34 LINK C ASN A 253 N CME A 254 1555 1555 1.34 LINK C CME A 254 N ILE A 255 1555 1555 1.33 SITE 1 AC1 10 ILE A 31 GLY A 32 GLU A 33 GLY A 34 SITE 2 AC1 10 ALA A 52 LYS A 54 GLN A 105 ASP A 106 SITE 3 AC1 10 LEU A 107 MET A 108 SITE 1 AC2 7 ARG A 191 ARG A 194 TYR A 233 HOH A 465 SITE 2 AC2 7 HOH A 542 HOH A 544 HOH A 626 CRYST1 48.687 69.411 59.721 90.00 108.99 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020539 0.000000 0.007068 0.00000 SCALE2 0.000000 0.014407 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017708 0.00000